Neuronetics, Inc. (STIM) Revenue Growth
Neuronetics, Inc. (STIM) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2019-12-31 | 18.72% |
| 2020-12-31 | -21.41% |
| 2021-12-31 | 12.32% |
| 2022-12-31 | 17.89% |
| 2023-12-31 | 9.42% |
| 2024-12-31 | 4.96% |
| 2025-12-31 | 99.17% |
How STIM compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc. | 94.10% |
| ADUS | Addus HomeCare Corporation | 23.21% |
| USPH | U.S. Physical Therapy Inc. | 16.33% |
| MCK | McKesson Corporation | 12.36% |
| MMSI | Merit Medical Systems Inc. | 11.75% |
These are five companies in the same sector as STIM with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Neuronetics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("STIM", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | STIM | $2.94 | -0.68% | 0.86M |
| 3 | ||||
| 4 | ||||
| 5 |